Cencora — Feb 2, 2026 release

Healthcare Solutions Segment (2) 14% to 16% growth $3.3B International Healthcare Solutions Segment (2)(3) 5% to 8% growth $588M Other (2) Flat $352M Adjusted diluted earnings per share $17.45 to $17.75 $16.00 Net interest expense $480M to $500M $292M Adjusted effective tax rate ~20% 20.6% Diluted weighted average shares outstanding 195.5M 195.2M Adjusted free cash flow ~$3.0B $3.0B Capital expenditures ~$900M $668M (1) Bolded figures indicate updates to guidance metrics. (2) For further detail on fiscal 2025 revised reportable segment information, please reference Exhibit 99.2 to the Company’s Current Report on Form 8-K dated November 5, 2025. (3) As reported guidance. For additional details regarding updated guidance expectations on a constant currency basis, please refer to our slide presentation for investors. Dividend Declaration     The Company’s Board of Directors declared a quarterly cash dividend of $0.60 per common share, payable March 2, 2026, to stockholders of record at the close of business on February 13, 2026. Conference Call & Slide Presentation The Company will host a conference call to discuss its operating results at 8:30 a.m. ET on February 4, 2026. A slide presentation for investors has also been posted on the Company’s website at investor.cencora.com. Participating in the conference call will be: • Robert P. Mauch, President & Chief Executive Officer • James F. Cleary, Executive Vice President & Chi